Rituximab (International)
In the US, Rituximab (rituximab systemic) is a member of the following drug classes: antirheumatics, CD20 monoclonal antibodies and is used to treat Bullous Pemphigoid, Chronic Lymphocytic Leukemia, Diffuse Large B-Cell Lymphoma, Evan's Syndrome, Focal Segmental Glomerulosclerosis, Follicular Lymphoma, Granulomatosis with Polyangiitis, Immune Thrombocytopenia, Mantle Cell Lymphoma, Microscopic Polyangiitis, Non-Hodgkin's Lymphoma, Pemphigus Vulgaris, Rheumatoid Arthritis and Thrombocytopenia.
US matches:
- Rituximab
- Rituximab and hyaluronidase human, recombinant
- Rituximab-abbs
- Rituximab-arrx
- Rituximab-pvvr
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
L01XC02
CAS registry number (Chemical Abstracts Service)
0174722-31-7
Chemical Formula
C6416-H9874-N1688-O1987-S44
Molecular Weight
143860
Therapeutic Categories
Immunosuppressant
Antineoplastic agent
Microtubule inhibitor
Biological response modifier, BRM
Anti-CD20 monoclonal antibody
Chemical Name
Immunoglobulin G 1 (human-mouse monoclonal IDEC-C2B8 gama 1-chain anti-human antigen CD 20), disulfide wit human-mouse monoclonal IDEC-C2B8 kapa-chain, dimer (WHO)
Foreign Names
- Rituximabum (Latin)
- Rituximab (German)
- Rituximab (French)
- Rituximab (Spanish)
Generic Names
- Rituximab (OS: BAN, DCF, USAN)
- Rituximab (Genetical Recombination) (OS: JAN)
- IDEC 102 (IDEC) (IS)
- IDEC C2B8 (IDEC) (IS)
Brand Names
- Acellbia
Biocad, Georgia - Blitzima
Celltrion, Estonia; Celltrion, Slovenia; Celltrion Healthcare, Sweden; Celltrion Healthcare Hungary, Poland - Mab Thera
Roche Registration, Slovenia - MabThera
F. Hoffmann-La Roche, Macedonia; F. Hoffmann-La Roche LTD, Serbia; Hoffmann-La Roche Ltd, Latvia; Productos Roche, Chile; Roche, Armenia; Roche, Argentina; Roche, Bosnia & Herzegowina; Roche, Belgium; Roche, Brazil; Roche, Colombia; Roche, Cyprus; Roche, Czech Republic; Roche, Denmark; Roche, Ecuador; Roche, Estonia; Roche, Egypt; Roche, Spain; Roche, Finland; Roche, France; Roche, Georgia; Roche, Greece; Roche, Hong Kong; Roche, Croatia (Hrvatska); Roche, Ireland; Roche, Italy; Roche, Lebanon; Roche, Lithuania; Roche, Moldova; Roche, Myanmar; Roche, Mexico; Roche, Norway; Roche, New Zealand; Roche, Oman; Roche, Peru; Roche, Philippines; Roche, Poland; Roche, Paraguay; Roche, Russian Federation; Roche, Sweden; Roche, Thailand; Roche, Tunisia; Roche, Turkey; Roche, Taiwan; Roche, Venezuela; Roche, Vietnam; Roche, South Africa; Roche D.O.O., Serbia; Roche Pharmaceutical, China; Roche Products, United Kingdom; Roche Registration, Romania; Roche Registration Limited, Iceland; Roche Uruguay, Uruguay - Mabthera
Roche, Germany; Roche, Pakistan; Roche Products, Australia; Roche Registration, Netherlands - MabThera 100mg
Haemato Pharm, Austria; Inopha, Austria; Orifarm, Austria; Roche, Hungary; Roche, Luxembourg; Roche Registration, Austria; Roche Pharma Schweiz, Switzerland - MabThera 10mg/ml
Roche, Israel - MabThera 1400mg
Haemato Pharm, Austria; Orifarm, Austria; Roche, Israel; Roche Registration, Austria; Roche Pharma Schweiz, Switzerland - Mabthera 1400mg/11.7ml
Roche, Luxembourg - Mabthera 1600mg/13.4ml
Roche, Luxembourg - MabThera 500mg
Haemato Pharm, Austria; Inopha, Austria; Orifarm, Austria; Roche, Hungary; Roche, Luxembourg; Roche Registration, Austria; Roche Pharma Schweiz, Switzerland - MabThera SC
Roche, Brazil; Roche Products, Australia - Novex
Elea, Argentina - Reditux
Complex Therapeutics, Chile; Dr Reddy's Lab, Myanmar; Dr. Reddy's Laboratories, Vietnam - Rilast
Hetero, Georgia - Ritemvia
Celltrion, Estonia; Celltrion Healthcare, Latvia; Celltrion Healthcare, Netherlands; Orion Pharma, Denmark; Orion Pharma, Finland; Orion Pharma, Sweden - Ritemvia 500mg
Celltrion Healthcare, Austria - Rituxan
Genentech, United States; Hoffmann-La Roche, Canada; Zenyaku Kogyo, Japan - Rituxan Hycela [+ Hyaluronidase]
Genentech, United States - Rituximab
Baxter, New Zealand - Rituzena
Celltrion Healthcare, Latvia; Celltrion Healthcare, Netherlands; Celltrion Healthcare, Sweden - Rixanthon
Sandoz, Latvia - Rixathon
Sandoz, Estonia; Sandoz, United Kingdom; Sandoz, Netherlands; Sandoz, Norway; Sandoz, Sweden; Sandoz, Slovenia; Sandoz GmbH, Greece - Rixathon 100mg
Hexal, Germany - Rixathon 100mg/10ml
Sandoz, Switzerland - Rixathon 500mg
Hexal, Germany - Rixathon 500mg/50ml
Sandoz, Switzerland - Riximyo
Sandoz, Estonia; Sandoz, Latvia; Sandoz, Netherlands; Sandoz, Sweden; Sandoz, Slovenia; Sandoz GmbH, Greece - Truxima
Biogaran, France; Celltrion, Georgia; Celltrion Healthcare, Lithuania; Celltrion Healthcare, Romania; Celltrion Healthcare Hungary Kft., Greece; Egis, Georgia; Kern Pharma, Spain; Mundipharma, Belgium; Mundipharma, Germany; Mundipharma Pharmaceuticals, Netherlands; Napp Pharmaceuticals, United Kingdom; Orion Pharma, Sweden - Truxima 100mg
Mundipharma, Luxembourg - Truxima 100mg/10ml
iQone, Switzerland - Truxima 500mg
Mundipharma, Luxembourg - Truxima 500mg/50ml
iQone, Switzerland - Tuxella
Celltrion, Estonia - Zytux
AryoGen, Georgia
Glossary
| Term | Definition |
|---|---|
| BAN | British Approved Name |
| DCF | Dénomination Commune Française |
| IS | Inofficial Synonym |
| JAN | Japanese Accepted Name |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
| WHO | World Health Organization |
Further information on drug naming conventions: International Nonproprietary Names.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.